Combined strategies lower pediatric CT radiation dose
The combination of tube current modulation and bismuth shields during pediatric chest CT scanning can reduce radiation dose with a minimal impact on image quality, according to researchers from Duke University and the University of Arkansas
The combination of tube current modulation and bismuth shields during pediatric chest CT scanning can reduce radiation dose with a minimal impact on image quality, according to researchers from Duke University and the University of Arkansas.
Although both techniques have been shown to effectively lower CT radiation dose, the effect of their combined use on dose reduction and image quality has never been assessed, according to coauthor Dr. Donald P. Frush, chief of pediatric radiology at Duke. On paper, it appeared that the scanner might increase the dose to penetrate the shield. The investigators tested shields on a childlike phantom after the scout CT scan used to determine tube current modulation. They found the technique lowered total dose by more than 50% with only minimal image noise (AJR 2008;190:W54-W61).
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
